Cargando…

Clinical Characteristics and Predictors of Outcome for Onconeural Antibody-Associated Disorders: A Retrospective Analysis

OBJECTIVE: To describe and analyze the clinical characteristics, laboratory data, management, and outcome of patients with onconeural antibody-associated disorders (OAAD) and identify predictors for poor outcome. METHODS: This was a retrospective review of all patients with potential OAAD, who were...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Shaohua, Qian, Ying, Hu, Huaiqiang, Niu, Bing, Guo, Hongwei, Wang, Xiaoling, Miao, Shuai, Li, Chuanfen, Cao, Bingzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694024/
https://www.ncbi.nlm.nih.gov/pubmed/29180979
http://dx.doi.org/10.3389/fneur.2017.00584
_version_ 1783280039990657024
author Liao, Shaohua
Qian, Ying
Hu, Huaiqiang
Niu, Bing
Guo, Hongwei
Wang, Xiaoling
Miao, Shuai
Li, Chuanfen
Cao, Bingzhen
author_facet Liao, Shaohua
Qian, Ying
Hu, Huaiqiang
Niu, Bing
Guo, Hongwei
Wang, Xiaoling
Miao, Shuai
Li, Chuanfen
Cao, Bingzhen
author_sort Liao, Shaohua
collection PubMed
description OBJECTIVE: To describe and analyze the clinical characteristics, laboratory data, management, and outcome of patients with onconeural antibody-associated disorders (OAAD) and identify predictors for poor outcome. METHODS: This was a retrospective review of all patients with potential OAAD, who were hospitalized in Jinan General Hospital between September 2009 and July 2017. We clarified the diagnosis, collected comprehensive information and categorized patients into three groups: paraneoplastic neurological disorders (PNDs), autoimmune encephalitis (AE), and possible OAAD. Within the three groups, we analyzed a range of clinical and laboratory parameters and used univariate and multivariate regression analysis to identify predictors for poor outcome [modified Rankin Scale (mRS) = 3–6]. RESULTS: From 158 patients, we identified 70 who fulfilled the criteria for OAAD, including 44 men (62.9%) and 26 women (37.1%). There were 38 patients (54.3%) in the PNDs group, 14 patients (20%) in the AE group, and 18 patients (25.7%) in the possible OAAD group. After the last follow-up, 14 (36.8%), 9 (64.2%), and 12 (66.7%) had a good outcome (mRS = 0–2). However, 6 (15.8%), 2 (14.3%), and 3 (16.7%) died, respectively. Univariate analysis showed that duration prior to the hospital (p = 0.0224) and urinary incontinence/retention (p = 0.0043) were associated with poor outcome (mRS = 3–6). After multivariate regression analysis, urinary incontinence/retention (p = 0.0388) and an immunocompromised state (p = 0.0247) remained as significant factors for poor outcome. CONCLUSION: Urinary incontinence/retention and an immunocompromised state represent significant predictors of a worse prognosis for patients with OAAD. By contrast, cerebrospinal fluid analysis showed that serum autoantibodies and tumor markers, the function of crucial organs, electrophysiology, and radiological findings were not associated with a poor outcome.
format Online
Article
Text
id pubmed-5694024
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56940242017-11-27 Clinical Characteristics and Predictors of Outcome for Onconeural Antibody-Associated Disorders: A Retrospective Analysis Liao, Shaohua Qian, Ying Hu, Huaiqiang Niu, Bing Guo, Hongwei Wang, Xiaoling Miao, Shuai Li, Chuanfen Cao, Bingzhen Front Neurol Neuroscience OBJECTIVE: To describe and analyze the clinical characteristics, laboratory data, management, and outcome of patients with onconeural antibody-associated disorders (OAAD) and identify predictors for poor outcome. METHODS: This was a retrospective review of all patients with potential OAAD, who were hospitalized in Jinan General Hospital between September 2009 and July 2017. We clarified the diagnosis, collected comprehensive information and categorized patients into three groups: paraneoplastic neurological disorders (PNDs), autoimmune encephalitis (AE), and possible OAAD. Within the three groups, we analyzed a range of clinical and laboratory parameters and used univariate and multivariate regression analysis to identify predictors for poor outcome [modified Rankin Scale (mRS) = 3–6]. RESULTS: From 158 patients, we identified 70 who fulfilled the criteria for OAAD, including 44 men (62.9%) and 26 women (37.1%). There were 38 patients (54.3%) in the PNDs group, 14 patients (20%) in the AE group, and 18 patients (25.7%) in the possible OAAD group. After the last follow-up, 14 (36.8%), 9 (64.2%), and 12 (66.7%) had a good outcome (mRS = 0–2). However, 6 (15.8%), 2 (14.3%), and 3 (16.7%) died, respectively. Univariate analysis showed that duration prior to the hospital (p = 0.0224) and urinary incontinence/retention (p = 0.0043) were associated with poor outcome (mRS = 3–6). After multivariate regression analysis, urinary incontinence/retention (p = 0.0388) and an immunocompromised state (p = 0.0247) remained as significant factors for poor outcome. CONCLUSION: Urinary incontinence/retention and an immunocompromised state represent significant predictors of a worse prognosis for patients with OAAD. By contrast, cerebrospinal fluid analysis showed that serum autoantibodies and tumor markers, the function of crucial organs, electrophysiology, and radiological findings were not associated with a poor outcome. Frontiers Media S.A. 2017-11-13 /pmc/articles/PMC5694024/ /pubmed/29180979 http://dx.doi.org/10.3389/fneur.2017.00584 Text en Copyright © 2017 Liao, Qian, Hu, Niu, Guo, Wang, Miao, Li and Cao. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Liao, Shaohua
Qian, Ying
Hu, Huaiqiang
Niu, Bing
Guo, Hongwei
Wang, Xiaoling
Miao, Shuai
Li, Chuanfen
Cao, Bingzhen
Clinical Characteristics and Predictors of Outcome for Onconeural Antibody-Associated Disorders: A Retrospective Analysis
title Clinical Characteristics and Predictors of Outcome for Onconeural Antibody-Associated Disorders: A Retrospective Analysis
title_full Clinical Characteristics and Predictors of Outcome for Onconeural Antibody-Associated Disorders: A Retrospective Analysis
title_fullStr Clinical Characteristics and Predictors of Outcome for Onconeural Antibody-Associated Disorders: A Retrospective Analysis
title_full_unstemmed Clinical Characteristics and Predictors of Outcome for Onconeural Antibody-Associated Disorders: A Retrospective Analysis
title_short Clinical Characteristics and Predictors of Outcome for Onconeural Antibody-Associated Disorders: A Retrospective Analysis
title_sort clinical characteristics and predictors of outcome for onconeural antibody-associated disorders: a retrospective analysis
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694024/
https://www.ncbi.nlm.nih.gov/pubmed/29180979
http://dx.doi.org/10.3389/fneur.2017.00584
work_keys_str_mv AT liaoshaohua clinicalcharacteristicsandpredictorsofoutcomeforonconeuralantibodyassociateddisordersaretrospectiveanalysis
AT qianying clinicalcharacteristicsandpredictorsofoutcomeforonconeuralantibodyassociateddisordersaretrospectiveanalysis
AT huhuaiqiang clinicalcharacteristicsandpredictorsofoutcomeforonconeuralantibodyassociateddisordersaretrospectiveanalysis
AT niubing clinicalcharacteristicsandpredictorsofoutcomeforonconeuralantibodyassociateddisordersaretrospectiveanalysis
AT guohongwei clinicalcharacteristicsandpredictorsofoutcomeforonconeuralantibodyassociateddisordersaretrospectiveanalysis
AT wangxiaoling clinicalcharacteristicsandpredictorsofoutcomeforonconeuralantibodyassociateddisordersaretrospectiveanalysis
AT miaoshuai clinicalcharacteristicsandpredictorsofoutcomeforonconeuralantibodyassociateddisordersaretrospectiveanalysis
AT lichuanfen clinicalcharacteristicsandpredictorsofoutcomeforonconeuralantibodyassociateddisordersaretrospectiveanalysis
AT caobingzhen clinicalcharacteristicsandpredictorsofoutcomeforonconeuralantibodyassociateddisordersaretrospectiveanalysis